Table 1.
Length | Group | Unique Seq |
Seq Counts |
p-value |
---|---|---|---|---|
15–17 | nose-poke | 8244 | 2744.57 | 7.25E-08** |
15–17 | pseudo-training | 8244 | 2052.58 | |
15–17 | training | 8244 | 1778.35 | 0.0069** |
20–23 | nose-poke | 34801 | 14820.52 | 0.0036** |
20–23 | pseudo-training | 34801 | 20440.43 | |
20–23 | training | 34801 | 23633.06 | 4.59E-07** |
25–30 | nose-poke | 6410 | 703.23 | 0.436 |
25–30 | pseudo-training | 6410 | 666.31 | |
25–30 | training | 6410 | 43269.34 | 7.99E-07** |
31–35 | nose-poke | 219 | 19.5 | 2.20E-05** |
31–35 | pseudo-training | 219 | 59.62 | |
31–35 | training | 219 | 2153.03 | 0.017* |
Shown are the total number of unique sequences and total number of normalized sequence counts in each size class for each treatment group. Training and nose-poke groups are each compared to the pseudo-training control group.
p < 0.05 by t-test.
p < 0.01 by t-test.
Reprinted from Smalheiser et al (2011a) with permission.